{"Acute graft versus host disease": 40.98962384468704, "Acute graft versus host disease in intestine": 162.54282149464166, "Acute graft versus host disease in skin": 191.7586418440809, "Acute promyelocytic leukaemia": 80.76217224837043, "Acute respiratory distress syndrome": 17.10351741163306, "Adenovirus infection": 53.87190121599772, "Anaemia": 4.726986018840199, "Aplastic anaemia": 16.247896771933043, "Chronic graft versus host disease": 39.84050064061359, "Chronic graft versus host disease in skin": 192.51735717586604, "Cystitis haemorrhagic": 41.35647694111013, "Cytomegalovirus infection reactivation": 80.80282490665593, "Deafness": 18.3052108148416, "Febrile neutropenia": 20.523005794198767, "Focal nodular hyperplasia": 679.6024211412794, "Graft versus host disease in gastrointestinal tract": 177.81909816834084, "Graft versus host disease in skin": 66.86096760754364, "Haematotoxicity": 34.0783825233434, "Hepatotoxicity": 15.106087171396371, "Leukopenia": 2.961004387297439, "Medulloblastoma recurrent": 2815.918222338205, "Mucosal inflammation": 62.6153191884963, "Multiple organ dysfunction syndrome": 4.057598456527057, "Myelodysplastic syndrome": 13.236047168380043, "Myelosuppression": 4.700370594290437, "Nervous system disorder": 14.202169728341207, "Neurotoxicity": 10.093362038127054, "Neutropenia": 14.358787677272758, "Off label use": 3.175916712856761, "Osteosarcoma": 502.9693174763792, "Pancytopenia": 2.3438655669244155, "Platelet count decreased": 2.7444765210459163, "Pneumonia cytomegaloviral": 65.051301155106, "Product use in unapproved indication": 5.141070670342077, "Pulmonary arterial hypertension": 17.042966491558634, "Respiratory distress": 3.198589154126713, "Second primary malignancy": 28.662096829500527, "Sepsis": 5.875374627324435, "Short stature": 605.5471836042957, "Stomatitis": 5.199218308356958, "Thrombocytopenia": 13.791380866636636, "Thrombotic microangiopathy": 28.27481572516789, "Venoocclusive liver disease": 49.76301641465533, "Visual impairment": 6.677342690487749}